INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV)

CUSIP: 45409B412

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / IQ S&P HGH YLD
Total 13F shares
3,386,079
Share change
-2,952,404
Total reported value
$81,384,000
Price per share
$24.11
Number of holders
14
Value change
-$70,949,759
Number of buys
6
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 45409B412?
CUSIP 45409B412 identifies HYLV - INDEXIQ ETF TR - IQ S&P HGH YLD in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) as of Q2 2018

As of 30 Jun 2018, INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,386,079 shares. The largest 10 holders included MACKAY SHIELDS LLC, NEW YORK LIFE INVESTMENT MANAGEMENT LLC, JANE STREET GROUP, LLC, DEUTSCHE BANK AG\, LPL Financial LLC, RAYMOND JAMES & ASSOCIATES, USAdvisors Wealth Management, LLC, BANK OF AMERICA CORP /DE/, IFP Advisors, Inc, and MORGAN STANLEY. This page lists 14 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.